These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18468815)

  • 1. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.
    Shoptaw S; Heinzerling KG; Rotheram-Fuller E; Steward T; Wang J; Swanson AN; De La Garza R; Newton T; Ling W
    Drug Alcohol Depend; 2008 Aug; 96(3):222-32. PubMed ID: 18468815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence.
    Heinzerling KG; Gadzhyan J; van Oudheusden H; Rodriguez F; McCracken J; Shoptaw S
    J Adolesc Health; 2013 Apr; 52(4):502-5. PubMed ID: 23333007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment.
    Brensilver M; Heinzerling KG; Swanson AN; Telesca D; Furst BA; Shoptaw SJ
    Drug Alcohol Rev; 2013 Jan; 32(1):96-9. PubMed ID: 22385210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation.
    Brensilver M; Heinzerling KG; Swanson AN; Shoptaw SJ
    Drug Alcohol Depend; 2012 Sep; 125(1-2):169-72. PubMed ID: 22534658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men.
    Das M; Santos D; Matheson T; Santos GM; Chu P; Vittinghoff E; Shoptaw S; Colfax GN
    AIDS; 2010 Apr; 24(7):991-1000. PubMed ID: 20397286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial.
    McCann DJ; Li SH
    CNS Neurosci Ther; 2012 May; 18(5):414-8. PubMed ID: 22070720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.
    Schmitz JM; Stotts AL; Yoon JH; Northrup TF; Villarreal YR; Yammine L; Weaver MF; Carmody T; Shoptaw S; Trivedi MH
    J Subst Use Addict Treat; 2023 Aug; 151():208987. PubMed ID: 36822269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence.
    Shoptaw S; Heinzerling KG; Rotheram-Fuller E; Kao UH; Wang PC; Bholat MA; Ling W
    J Addict Dis; 2008; 27(1):13-23. PubMed ID: 18551884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bupropion sustained-release on cigarette craving after smoking cessation.
    Durcan MJ; Deener G; White J; Johnston JA; Gonzales D; Niaura R; Rigotti N; Sachs DP
    Clin Ther; 2002 Apr; 24(4):540-51. PubMed ID: 12017399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence.
    Heinzerling KG; Shoptaw S; Peck JA; Yang X; Liu J; Roll J; Ling W
    Drug Alcohol Depend; 2006 Dec; 85(3):177-84. PubMed ID: 16740370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
    Dean AC; London ED; Sugar CA; Kitchen CM; Swanson AN; Heinzerling KG; Kalechstein AD; Shoptaw S
    Drug Alcohol Depend; 2009 Nov; 105(1-2):48-55. PubMed ID: 19608354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use.
    Heinzerling KG; Swanson AN; Hall TM; Yi Y; Wu Y; Shoptaw SJ
    Addiction; 2014 Nov; 109(11):1878-86. PubMed ID: 24894963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.